Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Nureca Limited (NSE: NURECA), ISIN INE0DSF01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NURECA last traded at ₹299.35 (-0.98%), with a 52-week range of ₹204.00 to ₹376.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 70.68%, FIIs 0.22%, DIIs 0.24%, mutual funds 0.00%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.